Penn Medicine Abramson Cancer Center
J

Penn Medicine Abramson Cancer Center Updates on Managing CLL/SLL With Practical Considerations for Novel Agents

By Penn Medicine Abramson Cancer Center FEATURING Jordan Carter, Mitchell Hughes
By Penn Medicine Abramson Cancer Center FEATURING Jordan Carter, Mitchell Hughes
309 views
January 19, 2024

Chapters

Overview of CLL/SLL, Signs & Symptoms

00:00

Risk Factors & Diagnosing CLL/SLL

02:33

Genetic Testing & Prognostic Factors in CLL

03:44

Rai & Binet Staging Systems for CLL

09:11

Complications from CLL & Approach to Treatment

10:11

BTK Inhibitors for CLL: Ibrutinib, Acalabrutinib & Zanubrutinib

15:59

Venetoclax-Based Therapy & Side Effects

21:47

Anti-CD20 Monoclonal Antibody Therapy for CLL

25:23

Emerging Treatments & Complications Management for CLL

26:55

Comments 0
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Recommended

21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.3K views

·

8 months ago
22:29

1L Therapy in CLL: What Are the Best Options?

SOHO Brazil 2024

J. Burger

813 views

·

4 months ago
35:12

Clinical Practice Updates in CLL/SLL

Integrity CE

M. Cortese, D. Wallace, A. Niu

316 views

·

3 months ago
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

878 views

·

6 months ago
12:47

ASCO® 2023 Summary: "Experts Discuss Key Abstracts in CLL"

Insights from 2023 ASCO® Annual Meeting

S. O'Brien, C. Coombs

2.1K views

·

1 year ago
21:12

3L in CLL: The Best Options in a Patient Double-Refractory to Covale…

SOHO Brazil 2024

J. Burger

488 views

·

4 months ago
17:05

Frontline CLL Learnings From Phase 3 RESONATE-2, iLLUMINATE, and E19…

Cleveland Clinic Taussig Cancer Institute

A. Winter

2.4K views

·

1 year ago
03:06

CLL Treatment Sequencing: The Importance of First Choice

City of Hope

S. Rosen

310 views

·

4 months ago
15:17

Sequencing Therapies in CLL: The Importance of First-Line Treatment …

Nicole Lamanna

241 views

·

2 months ago
06:53

Fixed-Duration Treatment in CLL: Current Considerations

UCI Health

E. Brem

693 views

·

11 months ago
25:47

Practice-Changing Updates in Indolent B-Cell Lymphomas

Massachusetts General Hospital Cancer Center

J. Soumerai

355 views

·

5 months ago
19:14

Experts Discuss Highlights and Key Takeaways in CLL From ASCO® and E…

2024 ASCO® Annual Meeting Insights Hub

K. Rogers, J. Woyach

300 views

·

4 months ago
18:29

Single vs. Multiple Agents in 2L Therapy for CLL

SOHO Brazil 2024

J. Burger

337 views

·

4 months ago
24:33

Therapeutic Options in CLL in 2023: Choosing the Initial Therapy Wis…

Indy Hematology Review

J. Woyach

1.2K views

·

1 year ago
08:11

State-of-the-Art in CLL Treatment

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Cuneo

504 views

·

8 months ago
08:42

Venetoclax vs. BTKis in CLL Treatment

City of Hope

A. Danilov

250 views

·

4 months ago
06:56

Efficacy of Ibrutinib Arms Across ALPINE and ELEVATE-RR Trials in R/…

Insights from 2023 ASH Annual Meeting

M. Shadman

822 views

·

10 months ago
14:22

Impact of Ibrutinib Dose Modifications in CLL

Ruemu Birhiray

289 views

·

4 months ago
18:15

The Next Frontier of Targeted Therapy in Lymphoma

UChicago Medicine

K. Maddocks

234 views

·

3 months ago
06:59

R/R CLL: A Matching-Adjusted Indirect Comparison of Zanubrutinib vs.…

Constantine Tam

307 views

·

6 months ago
AUTOPLAY